背景:在日本,通过癌症登记处收集全面的癌症统计数据。然而,关于泌尿系癌症的数据很少在研究论文中总结或发表。
方法:这项回顾性研究是使用公开的泌尿系癌症统计数据进行的(前列腺癌[PCa],膀胱癌[BCa],以及日本的肾脏和泌尿道癌症[膀胱除外]),包括该部死亡率统计摘要,截至2015年的地区癌症登记处的癌症发病率统计数据,以及2016年的国家癌症登记处统计数据。我们检查了按年龄组分层的泌尿系癌症的发病率和死亡率。
结果:新的PCa病例数,BCa,2019年,肾癌和尿路癌(膀胱癌除外)分别为94,748、23,383和30,458,2022年的死亡人数分别为13,439,9,598和9,795。泌尿系癌症的发病率和死亡率一直在增加。自2000年以来,在年龄>85岁的个体中,泌尿系癌症的死亡率显著增加。男性BCa的发病率和死亡率以及肾癌和尿路癌(膀胱除外)明显高于女性。
结论:未来,高龄患者(>85岁)的泌尿系癌症将变得越来越重要。
BACKGROUND: In Japan, comprehensive cancer
statistics are collected through cancer registries. However, data on urological cancers are rarely summarized or published in research papers.
METHODS: This retrospective study was performed using publicly available statistical data on urological cancers (prostate cancer [PCa], bladder cancer [BCa], and cancers of kidney and urinary tract [except urinary bladder]) in Japan, including a summary of the Ministry\'s mortality
statistics, cancer incidence
statistics from the Regional Cancer Registries through 2015, and the National Cancer Registry
statistics from 2016. We examined the incidence and mortality rates of urological cancers stratified by age groups.
RESULTS: The number of new cases of PCa, BCa, and cancers of kidney and urinary tract (except urinary bladder) in 2019 was 94,748, 23,383, and 30,458, respectively, and the number of deaths in 2022 was 13,439, 9,598, and 9,795, respectively. The incidence and mortality rates of urological cancers have consistently increased. Since 2000, there has been a noteworthy increase in the mortality rate of urological cancers among individuals aged > 85 years. The incidence and mortality rates of BCa and cancers of kidney and urinary tract (except urinary bladder) were significantly higher in males than in females.
CONCLUSIONS: Urological cancers in very elderly patients (> 85 years) will become increasingly important in the future.